Clinical trial Recruiting at 1 site Interventional Ages 18 to 65

Cervical spinal cord stimulation for patients with disorders of consciousness after brain hemorrhage

Official title: The Safety and Efficacy of Short-term Cervical Spinal Cord Stimulation in Patients With Disorders of Consciousness After Intracerebral Hemorrhage: a Multicenter, Prospective, Randomized, Outcome-blind Interventional Study

Run by Beijing Tiantan Hospital · NCT05922644 · Data updated 2026-11-12

This study tests if a new treatment using spinal cord stimulation can help patients who are not fully awake after a brain bleed become more alert and aware.

More Stroke trials

Quick facts

Study typeInterventional
Ages18 Years to 65 Years
SexAll
Enrollment344 (estimated)
SponsorBeijing Tiantan Hospital
Academic / other
Locations1 site (Beijing, Beijing Municipality)
StatusRecruiting
StartedJuly 1, 2023
Main results expectedSeptember 1, 2026
Study endsSeptember 1, 2030
Registry record updatedJuly 3, 2023
Trial IDNCT05922644 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults aged 18 to 65 who have been in a state of DOC for more than 28 days following a cerebral hemorrhage.

Probably not a fit

Patients with secondary brain injuries, unstable vital signs, or contraindications for spinal cord surgery may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study investigates the effects of cervical spinal cord stimulation (SCS) on patients who have experienced disorders of consciousness (DOC) following intracerebral hemorrhage. Patients are divided into two groups: one receiving SCS treatment for 21 days and the other receiving conventional treatment. The goal is to assess whether SCS can promote wakefulness and improve consciousness levels in these patients. The study aims to provide a new therapeutic approach for DOC, which currently lacks effective treatments.

Why it matters

Potential benefit: If successful, this treatment could significantly enhance recovery and quality of life for patients with disorders of consciousness.

How similar studies have gone: While there is limited research on cervical spinal cord stimulation for DOC, other neuromodulation techniques have shown promise in similar contexts.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age between 18 and 65 years old
* Patients with postoperative consciousness disorders after cerebral hemorrhage for more than 28 days
* CRS-R score meets the MCS diagnosis
* Signed informed consent.

Exclusion Criteria:

* Secondary brain injury caused by arteriovenous malformation, cerebral aneurysm, cavernous hemangioma, brain tumor and carbon monoxide poisoning
* History of previous epileptic seizures
* Critical condition, unstable intracranial condition, risk of rebleeding
* Unstable vital signs requiring mechanical ventilation
* Contraindications for spinal cord surgery
* Severe sympathetic overactivity syndrome.

Where it's running

  • Beijing Tiantan Hospital, Capital Medical University
    Beijing, Beijing Municipality, China
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.